Page 21 - 2020_09-Haematologica-web

Editorials
assay is associated with increased levels of neutrophil extracellular
trap-related factors. Endocrine. 2017;56(2):298-307.
12. Santagostino E, Mancuso ME, Tripodi A, et al. Severe hemophilia with mild bleeding phenotype: molecular characterization and glob-
al coagulation profile. J Thromb Haemost. 2010;8(4):737-743.
13. Zekavat OR, Haghpanah S, Dehghani J, et al. Comparison of throm- bin generation assay with conventional coagulation tests in evalua- tion of bleeding risk in patients with rare bleeding disorders. Clin
Appl Thromb Hemost. 2014;20(6):637-644.
14. Tran HT, Sørensen B, Bjørnsen S, et al. Monitoring bypassing agent
therapy - a prospective crossover study comparing thromboelastom- etry and thrombin generation assay. Haemophilia. 2015;21(2):275- 283.
15. Tripodi A, Chantarangkul V, Novembrino C, Peyvandi F. Advances in the treatment of hemophilia: implications for laboratory testing.
Clin Chem. 2019;65(2):254-262.
16. Tripodi A, Legnani C, Chantarangkul V, et al. High thrombin gener-
ation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J Thromb Haemost. 2008;6(8):1327-1333.
17. van Hylckama Vlieg A, Baglin CA, Luddington R, et al. The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study. J Thromb Haemost. 2015;13(9):1642-1652.
18. Palareti G, Cosmi B, Legnani C, et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006;355 (17):1780-1789.
19. Eichinger S, Hron G, Kollars M, Kyrle PA. Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer. Clin Chem. 2008;54(12):2042-2048.
haematologica | 2020; 105(9)
2199